Written by Peizhe Lu
Introduction
Societal understandings of mental health disorders have evolved unevenly and often painfully. In the United States, conceptions of mental illness once shaped by witch trials, confinement, and coercive restraint have gradually given way to a modern psychiatric framework grounded in clinical science, patient autonomy, and public advocacy. Although contemporary American mental health care remains imperfect and inequitable, the rapid expansion of research capacity, clinical services, and public awareness, particularly during the twentieth century, represents a remarkable transformation. By contrast, several highly developed nations have not matched this pace of progress. Despite substantial economic and scientific capacity, they continue to lag in mental health recognition, diagnosis, and treatment.
China presents a particularly consequential case. As a nation with vast population size, growing global influence, and extensive public health infrastructure, its approach to mental health disorders carries implications not only for domestic well being but also for global health equity.
The China Question
As of 2024, China remains the world’s most populous country. Yet, despite a population exceeding one billion, the nation reported only approximately 25,000 registered psychiatrists in 2021. By comparison, the United States, with a population less than one quarter that of China, reported roughly 57,000 registered psychiatrists in 2023. This stark imbalance cannot plausibly be explained by biological or genetic differences among populations. Although genetics may influence individual vulnerability to mental illness, there is no evidence to suggest that population level genetic variation accounts for China’s limited psychiatric workforce or lower diagnostic rates relative to the United States.
A more compelling explanation lies in disparities in socioeconomic development, health system priorities, and cultural recognition of mental health disorders. While China has experienced extraordinary economic growth since the 1980s, deep pockets of poverty persist, particularly in rural regions. These communities often face limited access to medical services, inadequate health literacy, and reduced opportunities for early diagnosis. As described in frameworks such as Blue Marble Health, marginalized populations within middle income and high income countries are frequently overlooked despite national wealth. In China, however, the neglect of under resourced communities is often more pronounced than in comparable settings.
Economic constraints alone, however, do not fully account for China’s mental health gap. More fundamental is the limited recognition of mental health disorders as legitimate medical conditions warranting systematic diagnosis and sustained treatment.
Stigma, Indifference, and ADHD
Mental health disorders remain highly stigmatized across much of East Asia, particularly in China and Japan. This stigma carries measurable social and economic costs, including lost worker productivity, disrupted education, and intergenerational disadvantage. Among the spectrum of psychiatric conditions, attention deficit hyperactivity disorder, or ADHD, may be among the most consequential in its cumulative effects.
In the United States, ADHD was estimated to account for 143 to 266 billion dollars in incremental costs in 2012 alone, largely through lost wages, reduced productivity, and increased health care expenditures. Beyond macroeconomic losses, ADHD substantially impairs educational attainment and social development among affected children. These consequences are not confined to Western societies.
During the author’s early schooling in Dalian, China, classmates who exhibited symptoms consistent with ADHD were frequently ridiculed or ostracized rather than supported. Their difficulties with attention and impulse control were commonly interpreted as moral or motivational failings, rather than manifestations of a neurodevelopmental disorder. Such experiences were not exceptional, but reflective of broader societal attitudes at the time. Although public discourse surrounding mental health in China has improved over the past decade, stigma and misunderstanding remain pervasive.
The under diagnosis and under treatment of ADHD in China are therefore not simply consequences of limited funding or insufficient clinical capacity. They are also products of public indifference and misperception. Without widespread recognition of ADHD as a legitimate medical condition, advocacy for expanded services and evidence based treatment remains structurally constrained.
ADHD Through a Public Health Lens
ADHD is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, as a persistent pattern of inattention and or hyperactivity that interferes with functioning or development. Although ADHD is not an infectious disease, its population level impacts resemble those of many conditions traditionally prioritized in global health.
First, ADHD disproportionately affects under resourced communities. Children from lower income households face higher risks of developing ADHD and, when diagnosed, often encounter barriers to consistent treatment. These patterns parallel those observed in neglected tropical diseases, which similarly cluster in settings marked by poverty and limited access to care.
Second, ADHD exerts its most profound effects early in life. Like malaria or pediatric HIV, untreated ADHD disrupts educational trajectories and cognitive development. Across socioeconomic strata, children with ADHD demonstrate poorer academic performance and higher rates of grade repetition. Longitudinal studies further associate childhood ADHD with adverse occupational and psychosocial outcomes in adulthood.
Finally, ADHD imposes substantial macroeconomic costs. While the COVID 19 pandemic produced acute, visible losses in productivity and revenue, the cumulative economic burden of ADHD has accrued more quietly over decades. Projections suggest that its long term costs may rival those of major global health crises, with the added distinction that ADHD’s effects are chronic and enduring rather than episodic.
The Concept of a Social Reservoir
Although ADHD is not transmissible in the biological sense, its consequences propagate through families, schools, workplaces, and communities. Caregivers of individuals with ADHD experience elevated psychological stress and economic strain. Educational systems must allocate additional resources to accommodate affected students, while employers absorb productivity losses associated with untreated symptoms.
In this sense, societies themselves function as reservoirs for ADHD related harm. When diagnosis is delayed and treatment inaccessible, the disorder’s secondary effects accumulate and diffuse across social networks. This diffusion may help explain why nations that under prioritize mental health experience persistent educational and economic inefficiencies. ADHD is therefore not an isolated clinical condition, but a population level challenge requiring coordinated intervention.
China’s Mental Health Dichotomy
China has demonstrated substantial political will and financial commitment to public health, particularly in the domain of infectious disease control. By 2024, it possessed one of the world’s most extensively funded public health infrastructures. In 2019 alone, China invested approximately 450 million dollars in dengue prevention, surpassing expenditures in many dengue endemic countries.
Mental health care, however, remains conspicuously underfunded. In 2020, per capita government investment in psychiatric hospitals was approximately one dollar, compared with an average of over thirty five dollars in other high income countries. Workforce quality further compounds this deficit. National surveys indicate that a majority of psychiatrists practicing in China have received no systematic psychological training or professional supervision.
These deficiencies are amplified in rural regions. Disparities in life expectancy between urban and rural populations have widened in recent years, reflecting uneven access to health services. The COVID 19 pandemic further exposed these structural divides. Yet even where mental health resources exist, utilization remains strikingly low. More than ninety percent of individuals with diagnosed mental health disorders in China reportedly never seek professional treatment.
This pattern underscores a central paradox. Unlike infectious disease interventions, which are widely accepted and actively sought, mental health services remain underutilized and socially concealed. Public discourse around psychiatric conditions is rare and often derogatory. Terms associated with ADHD and autism spectrum disorder are frequently employed as insults rather than clinical descriptors, reinforcing stigma at the linguistic level.
Policy Pathways and Cultural Reform
Addressing ADHD in China requires interventions at both structural and cultural levels. Expanding resources in rural communities is essential. Although the integration of rural and urban health insurance systems marked progress, equal coverage does not equate to equitable access when income disparities remain extreme. Targeted subsidies for rural populations could reduce financial barriers and encourage engagement with mental health services.
Retention of qualified medical personnel in rural areas presents an additional challenge. The steady decline in rural health workers reflects strong economic incentives favoring urban practice. Enhanced government subsidies, loan forgiveness programs, and structured rural service pathways for early career physicians may help mitigate this imbalance.
Beyond resource allocation, however, meaningful reform depends on transforming public perception. The current Chinese terminology for ADHD emphasizes behavioral excess rather than neurodevelopmental dysfunction, inadvertently reinforcing trivialization and blame. A systematic reclassification, potentially adopting neutral alphanumeric nomenclature analogous to infectious disease labeling, could help reframe ADHD as a legitimate medical condition deserving of clinical attention and policy priority. Such rebranding would not eliminate stigma on its own, but it could facilitate more accurate public education and reduce pejorative misuse.
Conclusion
China’s under recognition and under treatment of ADHD reflect broader challenges in its mental health system, particularly in rural regions and in public attitudes toward psychiatric illness. Despite robust investment in infectious disease control, mental health remains marginalized in funding, workforce development, and societal discourse.
This analysis suggests that ADHD, though non communicable, warrants treatment with a level of urgency comparable to that afforded to infectious diseases. Its cumulative effects on education, productivity, and family stability pose long term risks to national and global well being. Future research should prioritize standardized diagnostic criteria across countries, rigorous assessment of ADHD’s economic burden in China, and evaluation of culturally responsive interventions to reduce stigma.
Reducing the global burden of mental health disorders will require sustained international cooperation and a willingness to challenge entrenched biases. In China and beyond, recognizing conditions such as ADHD as legitimate, treatable medical disorders is a necessary first step toward more equitable and effective health systems.
References
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Beland, L. P., Brodeur, A., & Wright, T. (2023). The short-term economic consequences of COVID-19: Exposure to disease, remote work and government response. PloS one, 18(3), e0270341. https://doi.org/10.1371/journal.pone.0270341
Brown, J. E. H., Young, J. L., & Martinez-Martin, N. (2022). Psychiatric genomics, mental health equity, and intersectionality: A framework for research and practice. Frontiers in psychiatry, 13, 1061705. https://doi.org/10.3389/fpsyt.2022.1061705
Choi, Y., Shin, J., Cho, K. H., & Park, E. C. (2017). Change in household income and risk for attention deficit hyperactivity disorder during childhood: A nationwide population-based cohort study. Journal of epidemiology, 27(2), 56–62. https://doi.org/10.1016/j.je.2016.09.004
Coghill, D., Soutullo, C., d’Aubuisson, C., Preuss, U., Lindback, T., Silverberg, M., & Buitelaar, J. (2008). Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child and adolescent psychiatry and mental health, 2(1), 31. https://doi.org/10.1186/1753-2000-2-31
Guo, B., Xie, X., Wu, Q., Zhang, X., Cheng, H., Tao, S., & Quan, H. (2020). Inequality in the health services utilization in rural and urban china: A horizontal inequality analysis. Medicine, 99(2), e18625. https://doi.org/10.1097/MD.0000000000018625
Han S, Su B, Zhao Y, et al. Widening rural–urban gap in life expectancy in China since COVID-19. BMJ Global Health 2023;8:e012646.
Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Archives of Disease in Childhood 2005;90:i2-i7.
Jakovljevic, M., Chang, H., Pan, J., Guo, C., Hui, J., Hu, H., Grujic, D., Li, Z., & Shi, L. (2023). Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985-2023. Cost effectiveness and resource allocation : C/E, 21(1), 59. https://doi.org/10.1186/s12962-023-00461-9
Joseph, A., Kosmas, C. E., Patel, C., Doll, H., & Asherson, P. (2018). Health-Related Quality of Life and Work Productivity of Adults With ADHD: A U.K. Web-Based Cross-Sectional Survey. Journal of attention disorders, 23(13), 1610–1623. https://doi.org/10.1177/1087054718799367
Liu, J., Ma, H., He, Y. L., Xie, B., Xu, Y. F., Tang, H. Y., Li, M., Hao, W., Wang, X. D., Zhang, M. Y., Ng, C. H., Goding, M., Fraser, J., Herrman, H., Chiu, H. F., Chan, S. S., Chiu, E., & Yu, X. (2011). Mental health system in China: history, recent service reform and future challenges. World psychiatry : official journal of the World Psychiatric Association (WPA), 10(3), 210–216. https://doi.org/10.1002/j.2051-5545.2011.tb00059.x
“Other Concerns and Conditions with ADHD.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 27 Sept. 2023, www.cdc.gov/ncbddd/adhd/conditions.html.
Sicular, T., Ximing, Y., Gustafsson, B., Li, S. (2008). The Urban-Rural Income Gap and Income Inequality in China. In: Wan, G. (eds) Understanding Inequality and Poverty in China. Studies in Development Economics and Policy. Palgrave Macmillan, London. https://doi.org/10.1057/9780230584259_2
Sun, K. S., Lam, T. P., Kwok, K. W., Lam, K. F., Wu, D., & Ho, P. L. (2020). Seasonal influenza vaccine uptake among Chinese in Hong Kong: barriers, enablers and vaccination rates. Human vaccines & immunotherapeutics, 16(7), 1675–1684. https://doi.org/10.1080/21645515.2019.1709351
Vardavas, C., Zisis, K., Nikitara, K., Lagou, I., Marou, V., Aslanoglou, K., Athanasakis, K., Phalkey, R., Leonardi-Bee, J., Fernandez, E., Condell, O., Lamb, F., Sandmann, F., Pharris, A., Deogan, C., & Suk, J. E. (2023). Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: a systematic review. BMJ open, 13(10), e077602. https://doi.org/10.1136/bmjopen-2023-077602
Yan, Ran. “Covid-19 Exposed Weaknesses in China’s Rural Healthcare.” – The Diplomat, thediplomat.com/2023/03/covid-19-exposed-weaknesses-in-chinas-rural-healthcare/. Accessed 26 Apr. 2024.
Yang, Y., Zhang, L., Li, M., Wu, X., Xia, L., Liu, D. Y., Liu, T., Liu, Y., Jiang, F., Tang, Y. L., Liu, H., & Kalow, N. J. (2022). Turnover Intention and Its Associated Factors Among Psychiatrists in 41 Tertiary Hospitals in China During the COVID-19 Pandemic. Frontiers in psychology, 13, 899358. https://doi.org/10.3389/fpsyg.2022.899358
Yin, H., Wardenaar, K. J., Xu, G., Tian, H., & Schoevers, R. A. (2020). Mental health stigma and mental health knowledge in Chinese population: a cross-sectional study. BMC psychiatry, 20(1), 323. https://doi.org/10.1186/s12888-020-02705-x
Yu, Y., Liu, Y., Ling, F., Sun, J., & Jiang, J. (2023). Epidemiological Characteristics and Economic Burden of Dengue in Zhejiang Province, China. Viruses, 15(8), 1731. https://doi.org/10.3390/v15081731